Heliotherapy in atopic dermatitis: a prospective study on climatotherapy using the SCORAD index.

Authors: Autio P (1) , Komulainen P , Larni HM
(1) Department of Dermatology, Military Central Hospital, Helsinki
Source: Acta Derm Venereol. 2002;82(6):436-40
DOI: 10.1080/000155502762064575 Publication date: 2002 E-Publication date: Not specified Availability: full text Copyright: © 2002 Taylor & Francis.
Language: English Countries: Not specified Location: Not specified Correspondence address: Autio P : pekka.autio@sunpoint.net


Article abstract

The aim of this study was to investigate the suitability and effectiveness of heliotherapy in moderate or severe atopic dermatitis in adults in the Canary Islands. A total of 216 patients participated on 6 different 2- or 3-week heliotherapy trips. Using the Severity Scoring of Atopic Dermatitis Index (SCORAD), the severity of atopic dermatitis was assessed prior to the start of heliotherapy, after 2 weeks and then 3 months after the end of heliotherapy. A quality-of-life questionnaire was later mailed to all participants. The mean SCORAD index was reduced by 70% after 2 weeks of heliotherapy and was still 45% lower 3 months after therapy (P<0.0001). At 3 months, the use of topical steroids was still significantly reduced (P<0.0001), whereas there was no significant (P=0.1166) change in the consumption of emollients. The quality of life of patients was improved and their self-treatment and working capacity was increased. As the longer 3-week period provided no significant additional advantage over a 2-week period, 2 weeks of heliotherapy can be considered optimal. In conclusion, heliotherapy is an effective and valuable therapeutic adjunct, especially in adults with severe atopic dermatitis.

Download the file : 436-440.pdf (130.8 KB) Find it online